Ruby E Koshy, MD
Neurology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 5
Offices
5 locations · Sutter Bay Medical Foundation · Faculty Physicians and Surgeons of Llusm
Hospitals listed: Riverside University Health System-Medical Center. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Koshy’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A105884 · Current
Licensed to practise in California · since 2008 · expires 2028-01-31 · Mangalore University, Kasturba Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Riverside University Health System-Medical CenterMoreno Valley, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Riverside University Health SystemPatients rate it 2 of 5 · 66% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.232, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
See every measure and the patient survey for Riverside University Health System-Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.232 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.38 (0.38 to 2.38) · 932 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.93 (0.56 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 191.06 (136.87 to 245.25) · 59 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 77 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.7 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.1 · 184 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,070 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 4,158 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.35 (0.15 to 0.55) · 4,169 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.15 to 5.76) · 582 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.6 (0 to 3.29) · 126 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.98 (0.38 to 3.58) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.8 (0.71 to 18.89) · 135 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.67 (0.57 to 8.78) · 125 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.16) · 159 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.38 (0 to 1.09) · 3,702 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 48 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.517 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.896 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.404 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 46 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 303 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7.1 · 162 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1 · 164 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 290 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6 (3.8 to 9.1) · 36 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.9 (8.1 to 16.7) · 36 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 60 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 151 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.3 to 17) · 127 cases | No different | Jan 2022 – Dec 2024 |
What patients said (416 patients answered, 10% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 65% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 37% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$8,058
Medicare paid this office $8,058 for 83 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 30 | $1,974 | $66 |
| Measurement of brain wave activity (eeg), awake and drowsy | 16 | $722 | $45 |
Who their Medicare patients are
83 Original Medicare patients in 2024. Average age 68 · Under 65 29% · Women 54% · Also on Medicaid 75% · Health risk score 2.39. Sicker patients than 9 in 10 peers; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Diabetes 51% · Stroke 48% · Depression 47% · Chronic kidney disease 31% · Coronary heart disease 30% · Heart failure 27% · Dementia 25% · COPD 24% · Atrial fibrillation 24%.
The office billed $37,737, Medicare allowed $10,946 and paid $8,058; for 125 services of 23 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 83 | 125 | 68 | 2.39 | $37,737 | $8,058 |
| 2023 | 75 | 123 | 67 | 2.15 | $32,210 | $6,999 |
| 2022 | 85 | 118 | 69 | 2.43 | $36,440 | $8,919 |
| 2021 | 108 | 133 | 67 | 2.16 | $41,830 | $9,397 |
| 2020 | 102 | 151 | 69 | 2.63 | $45,704 | $11,752 |
| 2019 | 87 | 122 | 64 | 2.24 | $42,760 | $9,614 |
| 2018 | 100 | 157 | 67 | 2.10 | $53,540 | $11,455 |
| 2017 | 108 | 149 | 65 | 2.27 | $44,195 | $10,415 |
| 2016 | 120 | 194 | 66 | 2.42 | $54,680 | $13,384 |
| 2015 | 125 | 234 | 66 | 2.27 | $85,175 | $21,737 |
| 2014 | 143 | 262 | 67 | 2.41 | $102,495 | $25,424 |
| 2013 | 112 | 183 | 66 | 2.70 | $56,340 | $12,978 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 25 | $1,614 | $65 |
| Muscle electrical test | 12 | $440 | $34 |
| Muscle electrical test | 11 | $219 | $14 |
2022: 2 services
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 29 | $2,430 | $81 |
| Return visit (30+ min) | 13 | $971 | $69 |
2021: 2 services
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 40 | $3,213 | $77 |
| Measurement of brain wave activity (eeg), awake and drowsy | 13 | $634 | $49 |
2020: 3 services
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 27 | $2,939 | $86 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,462 | $107 |
| Return visit (30+ min) | 12 | $1,003 | $67 |
2019: 4 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $2,755 | $102 |
| New patient visit (45+ min) | 14 | $1,169 | $83 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $916 | $76 |
| Return visit (30+ min) | 11 | $781 | $60 |
2018: 2 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 47 | $5,070 | $97 |
| Return visit (30+ min) | 17 | $1,262 | $60 |
2017: 3 services
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 48 | $3,894 | $76 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,994 | $111 |
| Short return visit (20+ min) | 17 | $703 | $33 |
2016: 4 services
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 59 | $4,961 | $80 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,329 | $111 |
| Measurement of brain wave activity (eeg), awake and drowsy | 18 | $854 | $47 |
| Measurement of brain wave activity (eeg), awake and asleep | 12 | $569 | $47 |
2015: 5 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $6,000 | $162 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 42 | $5,619 | $110 |
| Measurement of brain wave activity (eeg), awake and drowsy | 32 | $1,545 | $45 |
| Return visit (30+ min) | 13 | $1,009 | $59 |
| Measurement of brain wave activity (eeg), awake and asleep | 16 | $749 | $47 |
2014: 4 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $7,978 | $163 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,287 | $105 |
| Measurement of brain wave activity (eeg), awake and drowsy | 37 | $1,840 | $47 |
| Measurement of brain wave activity (eeg), awake and asleep | 22 | $1,013 | $46 |
2013: 4 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 45 | $4,700 | $100 |
| Measurement of brain wave activity (eeg), awake and drowsy | 38 | $1,922 | $44 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $1,026 | $79 |
| Short return visit (20+ min) | 15 | $588 | $28 |
Medicaid work
$2,001 in 2024
Medicaid paid $2,001 for 40 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Muscle electrical test | 26 | $1,031 |
| 1ST HOSP IP/OBS SF/LOW 40 | 14 | $970 |
| 2024 | 40 | 2 | 14 | $2,001 |
| 2023 | 58 | 2 | 17 | $2,861 |
| 2022 | 26 | 2 | 14 | $1,777 |
| 2021 | 42 | 2 | 14 | $3,637 |
| 2020 | 14 | 1 | 14 | $949 |
| 2019 | 83 | 2 | 16 | $7,349 |
| 2018 | 277 | 3 | 28 | $21,306 |
See the largest Medicaid services in earlier years
2023
| Muscle electrical test | 44 | $1,692 |
| Return visit (30+ min) | 14 | $1,169 |
2022
| Return visit (30+ min) | 12 | $1,147 |
| Muscle electrical test | 14 | $630 |
2021
| 1ST HOSP IP/OBS SF/LOW 40 | 30 | $2,360 |
| Return visit (30+ min) | 12 | $1,277 |
2020
| Return visit (30+ min) | 14 | $949 |
2019
| Return visit (30+ min) | 70 | $5,716 |
| New patient visit (45+ min) | 13 | $1,633 |
2018
| Return visit (30+ min) | 186 | $13,472 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 65 | $6,444 |
| Short return visit (20+ min) | 26 | $1,390 |
Drugs they prescribed that Part D paid
$31,748
Pharmacies billed $31,748 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 78) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
64 generic and 14 brand-name prescriptions · $31,748 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Topiramate | 21 | $157 | $7 |
Year by year
| 2024 | 78 | 19 | 0% (0) | 18% | $31,748 |
| 2023 | 66 | 19 | 0% (0) | None | $18,527 |
| 2022 | 63 | 20 | 0% (0) | None | $10,293 |
| 2021 | 104 | 24 | 0% (0) | None | $26,749 |
| 2020 | 78 | 23 | 0% (0) | None | $28,978 |
| 2019 | 54 | 19 | 0% (0) | None | $22,501 |
| 2018 | 123 | 25 | 0% (0) | 10% | $75,090 |
| 2017 | 162 | 26 | 0% (0) | 17% | $183,490 |
| 2016 | 201 | 30 | 0% (0) | 19% | $192,879 |
| 2015 | 213 | 35 | 0% (0) | None | $199,389 |
| 2014 | 158 | 23 | 0% (0) | None | $60,127 |
| 2013 | 109 | 16 | 0% (0) | None | $8,490 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Mycophenolate Mofetil | 12 | $535 | $45 |
| Topiramate | 16 | $227 | $14 |
2022: 1 drug
| Gabapentin | 11 | $279 | $25 |
2021: 1 drug
| Azathioprine | 14 | $651 | $47 |
2020: 1 drug
| Gabapentin | 13 | $192 | $15 |
2018: 2 drugs
| Pyridostigmine | 16 | $1,352 | $84 |
| Levetiracetam | 30 | $1,300 | $43 |
2017: 3 drugs
| Tecfidera | 16 | $111,156 | $6,947 |
| Levetiracetam | 15 | $1,212 | $81 |
| Pyridostigmine | 13 | $1,094 | $84 |
2016: 5 drugs
| Tecfidera | 30 | $186,437 | $6,215 |
| Levetiracetam | 35 | $872 | $25 |
| Carbidopa-Levodopa | 16 | $693 | $43 |
| Gabapentin | 22 | $416 | $19 |
| Prednisone | 15 | $127 | $8 |
2015: 7 drugs
| Tecfidera | 27 | $152,086 | $5,633 |
| Carbidopa-Levodopa | 27 | $1,263 | $47 |
| Levetiracetam | 26 | $1,051 | $40 |
| Pyridostigmine | 15 | $814 | $54 |
| Phenytoin Sodium Extended | 11 | $495 | $45 |
| Gabapentin | 12 | $221 | $18 |
| Topiramate | 13 | $122 | $9 |
2014: 3 drugs
| Levetiracetam | 62 | $3,330 | $54 |
| Topiramate | 21 | $434 | $21 |
| Carbamazepine | 12 | $156 | $13 |
2013: 2 drugs
| Levetiracetam | 56 | $2,761 | $49 |
| Topiramate | 12 | $274 | $23 |
Money from drug and device companies
$122 in 2025
| 2025 | 2 | 2 | None | $122 |
| 2024 | 2 | 5 | None | $141 |
| 2023 | 3 | 3 | None | $160 |
| 2021 | 2 | 3 | None | $135 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | General - Dbs | $104 | 1 payment
|
| Alexion Pharmaceuticals | None | $19 | 1 payment
|
See all 2 published payments
| Alexion Pharmaceuticals | Meals · 2025-06-12 | None | $19 |
| Boston Scientific | Meals · 2025-04-09 | General - Dbs | $104 |
See earlier years (2024, 2023, 2021)
2024: $141
| Abbvie | Botox | $107 | 4 payments
|
| Argenx US | Vyvgart | $34 | 1 payment
|
2023: $160
| Abbvie | Botox | $78 | 1 payment
|
| Argenx US | Vyvgart | $65 | 1 payment
|
| Novartis Pharmaceuticals | Kesimpta | $17 | 1 payment
|
2021: $135
| Viz.ai | Viz.Ai Lvo | $111 | 1 payment
|
| Novartis Pharmaceuticals | Kesimpta | $24 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 85.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1578741369
- Licence
- CA A105884California A105884: Current · expires 2028-01-31
- Group
- Sutter Bay Medical Foundation · Faculty Physicians and Surgeons of Llusm
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2008-02-05
- NPI last updated
- 2026-05-15
- NPI record certified
- 2026-05-15
This is when the NPI record was last certified, not a medical board exam.